Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06244303 · ClinicalTrials.gov registry record · Phase 3

Clinical Research Study to Assess the Efficacy of Two Brushing Regimens in the Reduction of Established Dental Plaque and Gingivitis.

A Phase 3 study of Gingivitis and Plaque, sponsored by Colgate Palmolive.

Completed
Registry status
Phase 3
Development phase
82
Enrollment target
1
Study location

NCT06244303: Completed Phase 3 study of Gingivitis and Plaque, sponsored by Colgate Palmolive.

NCT06244303 is a Phase 3 study of Gingivitis and Plaque that has completed, run by Colgate Palmolive. The registered enrollment target is 82 participants, below the 233-participant average among 25 other Gingivitis trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06244303, a Phase 3 study of Gingivitis and Plaque, has completed, sponsored by Colgate Palmolive.

COMPLETED
Registry status
Phase 3
Development phase
82 participants
Enrollment target
1
Study location

Study Summary

Qualified subjects will be enrolled and randomized to one of the two study groups based on their initial Plaque and Gingivitis scores. Subjects will be instructed to use the products according to the instructions provided. Subjects will return to the dental office for evaluation after 1-, 3-, 6-, and 12-weeks of unsupervised product use at home. All subjects will be followed for adverse events throughout the study

Primary Outcome

reductions in dental plaque

Conditions Studied

Interventions

  • DRUG manual Tooth Brush + Colgate Total TP (0.454% SnF, 1100 ppm F)
  • DRUG manual toothbrush + Colgate dental cream

Study Locations (1)

California

  • Mesa Dental Centre - Costa Mesa

Trial Details

FieldValue
Enrollment Target 82 participants
Start Date 2024-01-22
Est. Completion 2024-04-16
Phase Phase 3
Colgate Palmolive

51 total trials

What the finished NCT06244303 record still lists

NCT06244303 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 82 participants, a relatively small participant target, below the 233-participant average among 25 other Gingivitis trials with a reported enrollment target (65% lower).

The record links to 2 conditions, with Gingivitis appearing as the primary indexed condition, and to 2 interventions - of which manual Tooth Brush + Colgate Total TP (0.454% SnF, 1100 ppm F) is the first listed.

NCT06244303 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06244303 about?

NCT06244303 is a clinical study titled "Clinical Research Study to Assess the Efficacy of Two Brushing Regimens in the Reduction of Established Dental Plaque and Gingivitis.". Qualified subjects will be enrolled and randomized to one of the two study groups based on their initial Plaque and Gingivitis scores. Subjects will be instructed to use the products according to the instructions provided. Subjects will return to the dental office for evaluation after 1-, 3-, 6-, an...

What is the current status of trial NCT06244303?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 82 participants. The study started on 2024-01-22. Estimated completion is 2024-04-16.

What conditions does trial NCT06244303 study?

This clinical trial studies the following conditions: Gingivitis, Plaque.

What interventions are being tested in trial NCT06244303?

The interventions under investigation include: manual Tooth Brush + Colgate Total TP (0.454% SnF, 1100 ppm F) (DRUG), manual toothbrush + Colgate dental cream (DRUG).

Who is sponsoring clinical trial NCT06244303?

This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06244303 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gingivitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06244303's enrollment target sits among peer trials

82 17th of 25 higher than 9 of 25 other Gingivitis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Gingivitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03319901 · 82 participants · Phase 1

    Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL

  • NCT03493425 · 82 participants · Phase 2

    Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery

  • NCT04105270 · 82 participants · Phase 2

    RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

  • NCT04428658 · 82 participants · NA

    Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06244303, the US trial registry maintained by the National Library of Medicine. NCT06244303 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.